SOT 64th Annual Meeting and ToxExpo 2025
Orange County Convention Center, Orlando, Florida
March 16, 2025 - March 20, 2025The SOT Annual Meeting and ToxExpo brought together a global community of toxicologists and scientists from related disciplines. Check out our Exhibitor-Hosted Session and poster presentations from the event and browse our resources below to learn about our new HepatoXcell™ primary human hepatocytes that support predictive drug development and toxicity testing.
Did you miss us at booth #1161 and would like to speak to one of ATCC’s representatives about a product or service? Make an appointment with us so we can discuss your needs.
Check out Exhibitor-Hosted Session
Innovative Microphysiological Model Using HepatoXcell™ Primary Human Hepatocytes and Locsense Artemis
In this presentation, we discussed a novel microphysiological model designed to mimic the gut-hepatic barrier that utilizes ATCC HepatoXcell Primary Human Hepatocytes and Caco-2 cells. The model employs the Locsense Artemis instrument to measure transepithelial electrical resistance (TEER), providing insights into barrier integrity. This study highlights the model's potential for advancing our understanding of gut-liver interactions, offering a robust platform for drug testing and toxicity studies.
Speakers: Sujoy Lahiri, PhD, Lead Scientist, ATCC, and Susan Roelofs, PhD, CEO and Founder, Locsense
Date: March 18, 2025
Time: 1:45 PM – 2:45 PM
Location: W208C
Primary human hepatocytes are considered the gold standard for in vitro liver models due to their high predictive value in drug metabolism and toxicity studies. They can provide early insights into how a drug will behave in the human body, potentially reducing the risk of adverse effects in clinical trials. ATCC hepatocytes are meticulously isolated and characterized to ensure the highest quality and performance for your drug development and toxicity testing needs. Try our HepatoXcell™ primary human hepatocytes and media today!
Learn moreGet a copy of our posters
Development and Characterization of an Immortalized Human Dermal Fibroblast Cell Line That Retains Primary Cell Functionality
Presenter: Xiangshan Zhao, PhD, Senior Scientist, ATCC
Location: Orange County Convention Center, ToxExpo Hall
Date: Monday, March 17, 2025
Time: 1:45 PM – 4:15 PM
Abstract number: 3124
Poster board number: D236
Innovative Microphysiological Model Using HepatoXcell™ Primary Human Hepatocytes and Locsense Artemis
Presenters: Eline Geervliet, MS, Application Scientist, Locsense, and Sujoy Lahiri, PhD, Lead Scientist, ATCC
Location: Orange County Convention Center, ToxExpo Hall
Date: Thursday, March 20, 2025
Time: 8:30 AM – 11:30 AM
Abstract number: 5186
Poster board number: LB287
Meet the presenters
Xiangshan Zhao, PhD
Senior Scientist, Cell Biology R&D, ATCC
Xiangshan Zhao, PhD, is a Senior Scientist at ATCC. He has extensive experience in cell line development and cell-based assay development. Dr. Zhao leads the Immortalized Primary Cells program developing innovative immortalized cell lines for research, drug screening, cell therapy, and toxicology studies.
Eline Geervliet, PhD
Application Scientist, Locsense
At Locsense, Eline Geervliet, bridges the gap between scientific research and practical applications. There, her primary goal is to improve in vitro detection of several toxicological models, thereby reducing the necessity for in vivo testing. Eline Geervliet completed her PhD at the University of Twente, in close collaboration with RWTH Aachen, where she developed novel in vitro models to mimic different organs to investigated novel therapeutic targets. She received her Masters at the University of Twente, where she investigated pH-responsive smart polymersomes for MMP-1 delivery and treatment of liver cirrhosis.
Sujoy Lahiri, PhD
Lead Scientist, R&D, ATCC
Sujoy Lahiri, PhD, is an R&D scientist in ATCC. He leads the primary cell division, working on advanced cellular models using primary cells as well as expansion of ATCC’s primary cell portfolio. Dr. Lahiri has extensive knowledge in the field of toxicology and drug metabolism.
Contact us today
Your ATCC sales representative stands ready to discuss your research needs and provide you with personalized care. Please complete our form to let us know how we can help, and we will start working on your needs right away.
